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Introduction
Damage via generation of free radicals has been implicated
in the pathogenesis of systemic lupus erythematosus
(SLE). Numerous studies demonstrate both direct and sur-
rogate evidence for a high burden of oxidative and nitra-
tive stress which parallels disease activity. Antioxidants
such as superoxide dismutase (SOD) function to protect
against oxidative damage by neutralizing free radicals and
levels are typically elevated in situations of high oxidative
stress.
Objectives
To examine the activity of the antioxidant enzyme SOD
in patients with the juvenile onset SLE (JSLE).
Methods
Serum was obtained form 49 patients with JSLE attend-
ing the adolescent rheumatology clinic at University
College London Hospital, 166 juvenile idiopathic arthri-
tis (JIA) disease controls, and 17 healthy adolescent con-
trols (median age at sampling 19.02 [IQR 17.00-20.67],
16.37 [IQR 10.41-18.04], and 14.78 [IQR 10.22-23.03]
respectively). Median duration of disease was 8.00 [IQR
4.42-10.38] years for JSLE and 6.30 [IQR 2.41-10.96]
years for JIA. Female: male ratio was 41:8 (83.7% female)
in JSLE patients, 95:71 (57.2% female) in JIA patients,
and 11:5 (64.7% female) in HC. SOD activity was mea-
sured using a commercial colorimetric assay.
Results
Surprisingly, no statistically significant difference in SOD
activity was observed between JSLE (median = 4.04 U/ml
[IQR 2.79-8.06]) and healthy controls (median = 4.03
U/ml [IQR 2.18-6.48]) though SOD activity was raised in
patients with JIA (median = 6.38 U/ml [IQR 4.83-8.70])
compared to controls and JSLE (p = 0.0009 and p =
0.0036 respectively). There was also no difference in
SOD activity when JSLE patients were subdivided into
serologically active and inactive disease groups based on
complement 3 and anti-double stranded DNA antibody
levels. Moreover, SOD activity levels did not vary with
organ involvement and remained normal in patients trea-
ted with disease modifying antirheumatic drugs
(DMARDs) or a combination of DMARDs and steroids.
Conclusion
Given the established role of oxidative stress in pathol-
ogy of SLE, it is surprising that SOD activity is not ele-
vated in our cohort of JSLE patients. A blunted
antioxidant response may have aetiopathogenic implica-
tions that warrant further investigation. Multivariate
analysis to correct for factors that may differ between
the groups, such as prednisolone use, are underway.
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